home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Vir Biotechnology, Inc. - Common Stock (NQ:VIR)

5.940 -0.090 (-1.49%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vir Biotechnology, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

What 8 Analyst Ratings Have To Say About Vir Biotechnology ↗

April 04, 2023

Via Benzinga

Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information ↗

March 21, 2023

Via Benzinga

Biotech Stocks And The SVB Collapse — Here's What We Know ↗

March 14, 2023

The collapse of SVB will have a big impact on early-stage, venture-backed companies.

Via Investor's Business Daily

Vir Biotechnology to Participate in the Barclays Global Healthcare Conference

March 08, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023 ↗

March 06, 2023

Via Benzinga

Where Vir Biotechnology Stands With Analysts ↗

February 24, 2023

Via Benzinga

Vir Biotechnology Gets Price Targets Cuts By Analysts After Q4 Results ↗

March 06, 2023

Vir Biotechnology, Inc. (NASDAQ: VIR) reported worse-than-expected Q4 results. Vir Biotechnology posted a Q4 loss of $0.76 per share, versus market expectations of $0.39 per share. The company’s...

Via Benzinga

The Top 7 Growth Stocks in Biotech ↗

March 03, 2023

The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.

Via InvestorPlace

Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference

February 28, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Coronavirus Vaccine Market To Surpass $95 Billion By 2028

February 28, 2023

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

Via FinancialNewsMedia

Vir Biotechnology's Earnings Outlook ↗

February 22, 2023

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

February 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 23, 2023

Via Benzinga

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

February 23, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

NVIDIA To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Thursday ↗

February 23, 2023

Goldman Sachs boosted the price target for Vir Biotechnology, Inc. (NASDAQ: VIR) from $41 to $53. Goldman Sachs analyst Paul Choi maintained a Buy rating on the stock. Vir Biotechnology shares rose...

Via Benzinga

Vir Biotechnology Announces Positive Final Draft Guidance on Sotrovimab from the UK’s National Institute for Health and Care Excellence (NICE)

February 22, 2023

Final draft guidance based on cost effectiveness evaluation of sotrovimab

From Vir Biotechnology, Inc.

Via GlobeNewswire

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 21, 2023

Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.

Via Benzinga

Manitowoc, Helix Energy Solutions, JELD-WEN Holding And Other Big Stocks Moving Higher On Tuesday ↗

February 21, 2023

U.S. stocks traded lower, with the Dow Jones dropping around 450 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023 ↗

February 21, 2023

Via Benzinga

DraftKings To Rally Around 38%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

February 21, 2023

Wells Fargo boosted the price target for Deere & Company (NYSE: DE) from $485 to $510. Wells Fargo analyst Seth Weber maintained an Overweight rating on the stock. Deere shares fell 0.5% to $431.08 in...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 21, 2023

Via Benzinga

Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

February 16, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Vir Biotechnology Appoints Sung Lee as Chief Financial Officer

February 16, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Vir Biotech To Work On Next-Gen COVID-19 Solutions Independently, Or With Other Partners, As GSK Walks Out ↗

February 14, 2023

Vir Biotechnology Inc (NASDAQ: VIR) has amended the research collaboration agreement established with GSK plc (NYSE: GSK) in 2020.

Via Benzinga

Outset Medical, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

February 14, 2023

Don’t forget to check out our premarket coverage here Fate Therapeutics, Inc. (NASDAQ: FATE) fell 4.1% to $6.13 in pre-market trading. Fate Therapeutics is expected to report Q4 results on Tuesday,...

Via Benzinga

Vir Biotechnology Announces Amended Collaboration Agreement with GSK

February 13, 2023

From Vir Biotechnology, Inc.

Via GlobeNewswire

Insiders Selling Meta Platforms And 3 Other Stocks ↗

February 10, 2023

The Nasdaq dropped by more than 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

The 7 Most Undervalued Biotech Stocks to Buy in February 2023 ↗

February 02, 2023

Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

Via InvestorPlace

7 Healthcare Stocks That Will Be Big Winners in 2023 ↗

January 31, 2023

Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com